NCT02427386

Brief Summary

Endometriosis is a chronic inflammatory disease that causes pelvic pain difficult to treat. In view of this, many patients seek assistance in complementary and alternative medicine, including homeopathic treatment. The absence of evidence in the literature raises controversy about the effectiveness of homeopathic treatment in endometriosis. The aim of this randomized trial is to evaluate the effectiveness of dynamized estrogen compared to placebo in the treatment of chronic pelvic pain of endometriosis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2014

Typical duration for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 28, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

February 24, 2017

Status Verified

February 1, 2017

Enrollment Period

1.8 years

First QC Date

April 22, 2015

Last Update Submit

February 22, 2017

Conditions

Keywords

EndometriosisPelvic painHomeopathyRCT

Outcome Measures

Primary Outcomes (1)

  • chronic pelvic pain (measured by visual analog scale (VAS-Pain)

    chronic pelvic pain (dysmenorrhoea, dyspareunia, acyclic pelvic pain depth, cyclic intestinal change and cyclic urinary change) measured by visual analog scale (VAS-Pain)

    24 weeks (6 months)

Secondary Outcomes (1)

  • 36-Item Short-Form Health Survey (SF-36)

    24 weeks (6 months)

Study Arms (2)

dynamized estrogen in alcohol solution

ACTIVE COMPARATOR

Dynamized estrogen (17-beta estradiol) in the 12cH, 24cH and 18cH potencies.

Drug: dynamized estrogen

placebo (alcohol solution)

PLACEBO COMPARATOR

This arm received alcohol solution during the 24-week study duration.

Drug: placebo

Interventions

The dosage of the homeopathic medicine or placebo will be of 3 drops, 2 times a day throughout the period of study, and can be reduced in case of finding of homeopathic aggravation of symptoms. 30 ml bottles will be sufficient for the proposed dosage every 8 weeks of treatment (bimensal period).

Also known as: dynamized 17-beta estradiol
dynamized estrogen in alcohol solution

The dosage of the placebo (alcohol solution) will be of 3 drops, 2 times a day throughout the period of study.

Also known as: alcohol solution
placebo (alcohol solution)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • aged between 18 and 45;
  • diagnosis of endometriosis (endometrial ectopia) confirmed by imaging test (MRI or TVUS) or laparoscopy (biopsy);
  • chronic pelvic pain refractory to conventional hormone treatments and with intensity ≥ 5 on the visual analog pain scale (VAS-Pain: 0-10 points);
  • symptomatic individualization of patients according to adverse events of estrogen (minimum syndrome of maximum value).

You may not qualify if:

  • absence of clinical and laboratory diagnosis of menopause or
  • premature ovarian failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (5)

  • Teixeira MZ. 'New Homeopathic Medicines' database: A project to employ conventional drugs according to the homeopathic method of treatment. European Journal of Integrative Medicine 5(3): 270-278, 2013.

    BACKGROUND
  • Teixeira MZ, Podgaec S, Baracat EC. Protocol of randomized controlled trial of potentized estrogen in homeopathic treatment of chronic pelvic pain associated with endometriosis. Homeopathy. 2016 Aug;105(3):240-249. doi: 10.1016/j.homp.2016.03.002. Epub 2016 May 13.

    PMID: 27473545BACKGROUND
  • Teixeira MZ, Podgaec S, Baracat EC. Potentized estrogen in homeopathic treatment of endometriosis-associated pelvic pain: A 24-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol. 2017 Apr;211:48-55. doi: 10.1016/j.ejogrb.2017.01.052. Epub 2017 Jan 25.

    PMID: 28187404BACKGROUND
  • Teixeira MZ. Homeopathic use of modern medicines: utilisation of the curative rebound effect. Med Hypotheses. 2003 Feb;60(2):276-83. doi: 10.1016/s0306-9877(02)00386-9.

  • Teixeira MZ. New homeopathic medicines: use of modern drugs according to the principle of similitude. Homeopathy. 2011 Oct;100(4):244-52. doi: 10.1016/j.homp.2011.01.002.

Related Links

MeSH Terms

Conditions

EndometriosisPelvic Pain

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Marcus Z Teixeira, PhD

    University of Sao Paulo General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 22, 2015

First Posted

April 28, 2015

Study Start

May 1, 2014

Primary Completion

February 1, 2016

Study Completion

December 1, 2016

Last Updated

February 24, 2017

Record last verified: 2017-02